FDA OKs expanded use of Allergan’ Botox for pediatric patients with muscle stiffness

The FDA has approved AbbVie (NYSE:ABBV) company, Allergan’s sBLA that supports expanded use of BOTOX (onabotulinumtoxinA) for the treatment of spasticity (muscle stiffness) in pediatric patients 2 …
( read original story …)

---